Abiopharma

Incyte Japan annonce l’autorisation de Minjuvi® (tafasitamab) en association avec le rituximab et le lénalidomide pour le traitement du lymphome folliculaire récidivant ou réfractaire

Bruker - RI Research Instruments Announces Major Orders for Enabling Technology for the Gamma-Ray Source of the Extreme Light Infrastructure (ELI)

RI Research Instruments Announces Major Orders for Enabling Technology for the Gamma-Ray Source of the Extreme Light Infrastructure (ELI)

MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit®-Wound Gel

Incyte Japan gibt die Zulassung von Zynyz® (Retifanlimab) für die Erstlinienbehandlung von fortgeschrittenem Analkrebs bekannt

Incyte Japan annonce l’autorisation de Zynyz® (rétifanlimab) pour le traitement de première intention du cancer anal avancé

Marie Laplante: The Dancing Chemical Engineer Who Reached for the Stars

NeuroSense Confirms Favorable Safety and Tolerability of PrimeC in an Alzheimers Phase 2 Study

Anebulo Pharmaceuticals Announces Its Intent to Commence a Self Tender Offer

OneMedNet CEO Aaron Green Issues Letter to Shareholders Highlighting 2025